Cis-diamminedichloroplatinum (II). A new anticancer drug.
about
Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.Cisplatin nephrotoxicity and protection by milk thistle extract in rats.The protective effects of acetylsalicylic acid on free radical production in cisplatin induced nephrotoxicity: an experimental rat modelHypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycinCisplatin and aminoglycoside antibiotics: hearing loss and its prevention.Ototoxicity in dogs and cats.Electronic structural investigations of ruthenium compounds and anticancer prodrugs.Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion.Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland.Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysis.Severe sensorimotor neuropathy after cisplatin therapy.The frequencies of micronuclei induced by cisplatin in newborn rat astrocytes are increased by 50-Hz, 7.5- and 10-mT electromagnetic fieldsRisk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection.A retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature.Combination antiemetics for cisplatin chemotherapy.Induction of emesis in Suncus murinus by pyrogallol, a generator of free radicals.Platinums: extending their therapeutic spectrum.Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases.Criteria for the selection of second-generation platinum compounds.The Fruit Hull of Gleditsia sinensis Enhances the Anti-Tumor Effect of cis-Diammine Dichloridoplatinum II (Cisplatin).Cisplatin-based chemotherapy in a renal transplant recipient.Synthetic methods for the preparation of platinum anticancer complexes.Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics.Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.Preliminary study of a combination of adriamycin, bleomycin, and diamminedichloroplatinum in advanced cancer.Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule.Induction chemotherapy for advanced head and neck cancers: a literature review.Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide.[Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].The current role of cancer chemotherapy.Cisplatin-loaded Au-Au2S nanoparticles for potential cancer therapy: cytotoxicity, in vitro carcinogenicity, and cellular uptake.Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease.Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.Preferential energy- and potential-dependent accumulation of cisplatin-gutathione complexes in human cancer cell lines (GLC4 and K562): A likely role of mitochondria.Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways.Targeting cancer chemotherapy using a monoclonal antibody (NCC-LU-243) conjugated with mitomycin C.Embryotoxicity and teratogenicity of Cis-diamminedichloroplatinum.Selective cytoplasmic and membrane changes induced by cisplatinum.
P2860
Q24791211-2023F73C-C5DD-4377-A893-95A2122FA4DAQ24816659-AF056307-293C-4B3F-A31F-1869F884A70DQ28165840-E797AAC8-C4BA-4246-8C94-563F36B21753Q28336414-7F0D8963-FA49-48B5-855D-14C9B58368FDQ30447637-EBCF8CD1-5DC6-4735-B047-20BC773825B8Q30447867-4414C08C-F4C8-4915-9DE5-A84448783703Q33427427-EB4C91BD-1C85-4797-8EB6-17488E1B6DEAQ33452907-FB932DCC-ABC0-410E-973C-A3BFB51E83CBQ33485210-38B7B85F-E65F-43EC-893C-27D54389D147Q33485404-BA981807-B0A7-4A9E-AFF7-40A53648BB7FQ33497993-FF34034B-2DFE-463D-93F8-226C7259A408Q33622080-A96C70FB-9E49-4490-9995-CBABB70C5392Q33854150-00C4BC69-79C2-42E4-84AC-2C5EB985BF83Q33895592-B928B06B-F212-4530-82C2-5CFA5A12EC6FQ34648601-3BA60F57-8C58-4E49-800E-9222CCD8917FQ34686969-391DE806-5CDD-482D-A927-96B83F505E57Q35874225-A57E7700-EFE2-455E-8DDB-E537FA6F25BAQ36028686-42466A11-CEA2-4852-98FD-E1D7ABB346BDQ36043600-E67A1802-C3DF-40F0-8C5F-E9557568CBB3Q36044721-C972B171-422A-47B6-8BE4-C7E430E47EACQ37303255-D24885EC-160B-4B41-BBE2-00E0CC00A9A9Q37365792-6FFF75FD-7D86-40BC-A55A-A430930E8DA8Q37722632-83BC5C7F-16EF-4E4E-A28E-D0C9958A87B9Q37978306-F7115920-DDEE-4F3A-9E5B-07F3EF75C340Q39109544-B07579DB-987C-4AB6-8263-EBABB2CBA5BFQ39399932-6A5E859A-D9BE-4C9B-B682-5FD2C954D222Q39535641-91BF5449-F580-4AD1-8185-3344E9CC2000Q39553251-1A17A5E3-8C9B-4922-AA8C-E16DCCB1B629Q39567732-E4398713-7563-450A-B427-5B735D9ECD85Q39568267-76079EDB-2B82-4408-A688-C0FF8792D734Q39718529-519C4FDC-B341-43E1-961F-3B555C0F35E6Q39776420-6632C729-E991-48E4-8D64-5390A8D5164AQ40076106-E48FB244-BE33-4C3D-A1A3-662FEF6FE22BQ40097510-3F2DAAC5-9920-459C-AB00-F10A56BF6313Q40273255-016452F7-35BC-4812-9504-CF23F0D43E51Q40274190-2EAEC8D8-F026-4956-98BD-BDDCD5ECFBD3Q40657611-7D6E4417-FC47-4AC1-9CED-56B954A358FFQ41602075-1A9C6B5B-0ED0-478C-8AA4-A0D51AA3FDDAQ41622675-E902A401-7482-434D-9BFA-A456749862F9Q41713275-424E20AE-14D6-402D-B986-BF0A87243108
P2860
Cis-diamminedichloroplatinum (II). A new anticancer drug.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Cis-diamminedichloroplatinum (II). A new anticancer drug.
@en
type
label
Cis-diamminedichloroplatinum (II). A new anticancer drug.
@en
prefLabel
Cis-diamminedichloroplatinum (II). A new anticancer drug.
@en
P2093
P1476
Cis-diamminedichloroplatinum (II). A new anticancer drug.
@en
P2093
Rozencweig M
von Hoff DD
P304
P356
10.7326/0003-4819-86-6-803
P407
P577
1977-06-01T00:00:00Z